MSD Czech Republic operates a 1,800-person pharmaceutical division anchored by the Prague Tech Center, one of four global hubs driving digital transformation for the parent company. The tech stack reveals heavy SAP enterprise systems (WM, MM, R/3, Commerce Cloud) paired with modern cloud infrastructure (AWS, Azure, GCP) and data platforms (dbt Cloud, Matillion, Azure Data Explorer), suggesting a company mid-migration from legacy ERP toward hybrid cloud-native operations. Active hiring skews heavily toward engineering (24 roles) and data (7), with senior-level dominance, indicating focus on building internal capability rather than outsourcing.
MSD Czech Republic is a pharmaceutical manufacturing and commercial subsidiary of MSD, employing over 1,800 people across divisions including commercial, finance, technology, and operations. The Prague Tech Center serves as a regional hub for AI, cloud, software engineering, data analytics, and cybersecurity capabilities supporting the global parent organization. The company develops therapies and vaccines across oncology, immunology, infectious diseases, and cardiometabolic disorders, with parallel animal health operations. Current priorities include post-acquisition integration, order-to-cash digitization, enterprise-scale security analytics (Sentinel SIEM), and cost optimization across cloud and data platforms.
Primary: SAP (WM, MM, R/3, Commerce Cloud, BTP), AWS, Azure, GCP. Data layer: dbt Cloud, Matillion, Azure Data Explorer, Cribl. Security/observability: Microsoft Sentinel, MITRE ATT&CK. Infrastructure: Kubernetes, Terraform, Docker, CloudFormation, GitHub Actions.
Key initiatives: enterprise security telemetry/SIEM platform, cloud cost optimization, serialization implementation, order management digitization, post-acquisition company integration, and scalable data ingestion pipelines using Azure Data Explorer and Sentinel.
Other companies in the same industry, closest in size